7th Annual General Meeting

Shareholders approve all proposals - Seite 2

 

Sustainable and stable dividend

The Annual General Meeting also approved the dividend at the prior-year level of CHF 2.20 per share proposed by the Board of Directors. Half (CHF 1.10 per share) is paid out from the capital contribution reserve and the other half from retained earnings. This corresponds to a total expected distribution of CHF 109.6 million. Galenica strives to achieve strong and sustainable dividend growth and plans to pay a dividend equal at least to the previous year’s level in 2024. The dividend for the 2023 financial year will be paid to shareholders from 16 April 2024.

Dates for the diary

23 May 2024:	Galenica Group sales update
6 August 2024:	Galenica Group half-year results 2024
24 October 2024:	Galenica Group sales update

 

For further information, please contact:

 

Media Relations: E-Mail: [e-mail] Tel. [phone]

Investor Relations: E-Mail: [e-mail] Tel. [phone]

Welcome to the Galenica network!
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market. We offer fully integrated solutions both for customers and patients as well as for pharmacies, drugstores, medical practices, hospitals, retirement and nursing homes, home care providers, wholesalers, pharmaceutical companies, health insurance funds and other partners.